These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16053515)

  • 21. [Progress of EBNA1/oriP-based plasmid applied in gene therapy].
    He J; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):507-10. PubMed ID: 16108385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
    Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
    Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The therapeutic potential of attenuated diphtheria toxin delivered by an adenovirus vector with survivin promoter on human lung cancer cells.
    Dai L; Yu X; Huang S; Peng Y; Liu J; Chen T; Wang X; Liu Q; Zhu Y; Chen D; Li X; Ou Y; Zou Y; Pan Q; Cao K
    Cancer Biol Ther; 2021 Jan; 22(1):79-87. PubMed ID: 33377426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene.
    Kunitomi M; Takayama E; Suzuki S; Yasuda T; Tsutsui K; Nagaike K; Hiroi S; Tadakuma T
    Jpn J Cancer Res; 2000 Mar; 91(3):343-50. PubMed ID: 10760695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.
    Cemazar M; Sersa G; Wilson J; Tozer GM; Hart SL; Grosel A; Dachs GU
    Cancer Gene Ther; 2002 Apr; 9(4):399-406. PubMed ID: 11960291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
    Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
    Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Massive apoptotic cell death in chemically induced rat urinary bladder carcinomas following in situ HSVtk electrogene transfer.
    Shibata MA; Horiguchi T; Morimoto J; Otsuki Y
    J Gene Med; 2003 Mar; 5(3):219-31. PubMed ID: 12666188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-targeted gene therapy for nasopharyngeal carcinoma.
    Li JH; Chia M; Shi W; Ngo D; Strathdee CA; Huang D; Klamut H; Liu FF
    Cancer Res; 2002 Jan; 62(1):171-8. PubMed ID: 11782375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of Epstein-Barr virus-based expression vector containing mini-oriP.
    Tanaka J; Miwa Y; Miyoshi K; Ueno A; Inoue H
    Biochem Biophys Res Commun; 1999 Nov; 264(3):938-43. PubMed ID: 10544034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
    Aiyar A; Tyree C; Sugden B
    EMBO J; 1998 Nov; 17(21):6394-403. PubMed ID: 9799247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined prokaryotic-eukaryotic delivery and expression of therapeutic factors through a primed autocatalytic positive-feedback loop.
    Shi L; Yu B; Cai CH; Huang W; Zheng BJ; Smith DK; Huang JD
    J Control Release; 2016 Jan; 222():130-40. PubMed ID: 26682504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia.
    Judde JG; Spangler G; Magrath I; Bhatia K
    Hum Gene Ther; 1996 Mar; 7(5):647-53. PubMed ID: 8845390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy strategies for treating Epstein-Barr virus-associated lymphomas: comparison of two different Epstein-Barr virus-based vectors.
    Kenney S; Ge JQ; Westphal EM; Olsen J
    Hum Gene Ther; 1998 May; 9(8):1131-41. PubMed ID: 9625252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel cytotoxic vectors based on adeno-associated virus.
    Kohlschütter J; Michelfelder S; Trepel M
    Toxins (Basel); 2010 Dec; 2(12):2754-68. PubMed ID: 22069574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electroporation-enhanced gene delivery in mammary tumors.
    Wells JM; Li LH; Sen A; Jahreis GP; Hui SW
    Gene Ther; 2000 Apr; 7(7):541-7. PubMed ID: 10819568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer.
    Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T
    Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene.
    Harrison GS; Long CJ; Curiel TJ; Maxwell F; Maxwell IH
    Hum Gene Ther; 1992 Oct; 3(5):461-9. PubMed ID: 1329991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells.
    Belt PB; Groeneveld H; Teubel WJ; van de Putte P; Backendorf C
    Gene; 1989 Dec; 84(2):407-17. PubMed ID: 2482230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
    Li Y; McCadden J; Ferrer F; Kruszewski M; Carducci M; Simons J; Rodriguez R
    Cancer Res; 2002 May; 62(9):2576-82. PubMed ID: 11980652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors.
    Cui FD; Kishida T; Ohashi S; Asada H; Yasutomi K; Satoh E; Kubo T; Fushiki S; Imanishi J; Mazda O
    Gene Ther; 2001 Oct; 8(19):1508-13. PubMed ID: 11593364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.